DaVita
DVA
#1743
Rank
A$17.17 B
Marketcap
A$267.55
Share price
23.46%
Change (1 day)
20.72%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): A$15.45

According to DaVita's latest financial reports the company's current EPS (TTM) is A$13.97. In 2024 the company made an earnings per share (EPS) of A$15.22 an increase over its 2023 EPS that were of A$10.50.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$15.451.47%
2024A$15.2244.94%
2023A$10.5027.26%
2022A$8.25-35.56%
2021A$12.8144.1%
2020A$8.8919.7%
2019A$7.42540.48%
2018A$1.16-76.07%
2017A$4.84-19.31%
2016A$6.00242.52%
2015A$1.75-62.87%
2014A$4.7213.43%
2013A$4.168.45%
2012A$3.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$32.39 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.53 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$20.29 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.64-81.08%๐Ÿ‡บ๐Ÿ‡ธ USA